Min Jung Koh
Papers
1
Total Citations
1
H-Index
1
About
Dr. Min Jung Koh is a radiation oncologist whose research centers on the intersection of radiation therapy, immunology, and treatment toxicity, with a particular focus on prostate cancer. Her work investigates the critical phenomenon of radiation-related lymphopenia—the depletion of lymphocytes following treatment—and its implications for patient outcomes. In her highly cited 2024 study, Dr. Koh examined how stereotactic body radiation therapy (SBRT) for prostate cancer, with or without supplemental pelvic irradiation, influences late lymphopenia. This research is pivotal because chronic lymphopenia may compromise both immune function and cancer control, challenging the conventional wisdom that hypofractionated regimens are uniformly safer. By quantifying the immunological cost of pelvic field coverage, Dr. Koh’s work provides essential data for optimizing treatment plans that balance tumor eradication with immune preservation. Her contributions are shaping a more nuanced understanding of how radiation fractionation and target volume affect the host immune system, directly informing clinical decision-making for prostate cancer patients. With her research gaining traction in the radiation oncology community, Dr. Koh is establishing herself as a key voice in the emerging field of radio-immunobiology.
Research Focus
Key Achievements
Top Papers
- 1